Indianapolis, IN · Founded 2020 · Privately Held (backing)
Operator of a pre-clinical stage biotechnology company intended to support a cancer treatment. Grannus Therapeutics is based in Indianapolis, IN and was founded in 2020. It was valued at $5 million at its seed round in Jan 2022, the last priced event on record. It has raised $2.9 million across 2 recorded rounds; the latest was an $800,000 debt round in Nov 2023.
PMV mark · valuation
$5.0M
Oct 2026
Priced at
its seed round
Jan 2022
Total raised
$2.9M
Last round
Debt
Nov 2023
Cap table — not yet on record
Grannus Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Grannus Therapeutics with a free account
·Watch Grannus Therapeutics: the Monday email on marks, rounds and moves
Where does Grannus Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Grannus Therapeutics's 2 recorded funding rounds.
